He points to GLP-1 receptors in the hypothalamus, saying the medication boosts fullness signals and slows the stomach, which changes how hunger feels.
Recap by typeshit. Video by @drmakkani on TikTok.
6:25
Dr Almerie compares Lilly's experimental retatrutide with Mounjaro and talks through the case for switching versus holding off until it's approved.
10:08
Weight loss doctor Bazgha Khalid goes through what the published trials actually show for Zepbound against Lilly's newer retatrutide.
Patients who took a GLP-1 receptor agonist before surgery did not lose more weight at one year, JAMA Surgery reports. The full study has the details.
A clinical piece for foot and limb care providers on how GLP-1 drugs relate to the lower extremity. Only the title is available.
She landed the Daily Mail front page this week discussing Ozempic face and the steps she says she took to protect her own.
Dr. Shah walks through how GLP-1s work, who stands to benefit, common side effects, and NorthShore's weight management clinic.
Loading…